 |
|
|
|
Please log in to determine if you are eligible to purchase PT Programs.
|
|
| MEASURABLE (MINIMAL) RESIDUAL DISEASE - MRD2 |
MRD2
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
- Three RNA specimens in sterile water
- For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of PML::RARA fusion transcripts
- Ships on dry ice
- For recommendations and requirements, see flow chart
Shipping Schedule
-
Shipment A: April 15
-
Shipment B: September 30
|
|
|
|
|
|
Help